Skip to content

Drug interactions

Fluticasone-vilanterol + Rucaparib

Severity: Minor

Fluticasone-vilanterol and Rucaparib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib is a weak-to-moderate CYP3A inhibitor and may modestly raise exposure to inhaled fluticasone furoate and vilanterol. Because inhaled systemic exposure is low, a clinically meaningful effect is unlikely in most patients.

What this interaction means in plain words

Fluticasone-vilanterol and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fluticasone-vilanterol belongs to Respiratory; Rucaparib belongs to Oncology.

Evidence level: Low

Why it happens

Rucaparib inhibits CYP3A4, reducing the first-pass and systemic clearance of fluticasone furoate and vilanterol.

What to do

No routine dose change is needed; monitor for beta-agonist effects such as tachycardia and tremor, and for corticosteroid systemic effects if used long term.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fluticasone-vilanterol and Rucaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fluticasone-vilanterol with Rucaparib?

MediHelp rates the interaction as minor. Fluticasone-vilanterol and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rucaparib is a weak-to-moderate CYP3A inhibitor and may modestly raise exposure to inhaled fluticasone furoate and vilanterol. Because inhaled systemic exposure is low, a clinically meaningful effect is unlikely in most patients.

How serious is the interaction between Fluticasone-vilanterol and Rucaparib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; monitor for beta-agonist effects such as tachycardia and tremor, and for corticosteroid systemic effects if used long term.

What other medicines interact with Fluticasone-vilanterol?

MediHelp also lists interactions of Fluticasone-vilanterol with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Fluticasone-vilanterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in